🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary purpose of this study is to determine the overall response rate...
Status
Withdrawn
Location
CEHON Centro de Hematologia e Oncologia da Bahia
Start Date
2019-09-30
Trial ID
NCT03608501
Treatments Being Tested
The purpose of this study is to evaluate the tolerability, safety, pharmaco...
Status
Terminated
Location
Multiple Locations
Start Date
2012-06-05
Trial ID
NCT04272775
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of ixazomi...
Status
Unknown
Location
PekingUMCH
Start Date
2021-07-26
Trial ID
NCT04989140
Treatments Being Tested
The purpose of this study is to evaluate the percentage of participants wit...
Status
Completed
Location
Pacific Cancer Medical Center
Start Date
2018-03-13
Trial ID
NCT03439293
Treatments Being Tested
The purpose of this study is to determine the long-term safety and tolerabi...
Status
Completed
Location
Beijing Chaoyang Hospital Capital Medical University
Start Date
2019-01-24
Trial ID
NCT03748953
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of ixazomi...
Status
Completed
Location
Multiple Locations
Start Date
2016-11-01
Trial ID
NCT02917941
Treatments Being Tested
The main purpose of this study is to establish a safe and tolerable dose co...
Status
Withdrawn
Location
Columbia University Medical Center
Start Date
2020-11
Trial ID
NCT03880123
The purpose of this study is to characterize the safety and tolerability of...
Status
Terminated
Location
Multiple Locations
Start Date
2014-06-09
Trial ID
NCT02176486
The main aim is to show that long-term use of ixazomib can improve symptoms...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-06-30
Trial ID
NCT05183139
Treatments Being Tested
This study will independently assess the efficacy and safety of 11 combinat...
Status
Recruiting
Location
Banner MD Anderson Cancer Center
Start Date
2015-10
Trial ID
NCT02343042